Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Elanco Animal Health Inc | 18,446,429 | reported | 03 Dec 2020 | tx 1−54,500,000 |
| Azitra, Inc. | 1,307,401 | reported | 21 Jun 2023 | tx 2+1,307,401−1,307,401 |
| Metagenomi Therapeutics, Inc. | 0 | reported | 13 Feb 2024 | tx 8+4,050,997−7,076,724 |
| Pyxis Oncology, Inc. | 0 | reported | 13 Oct 2021 | tx 3+2,742,338−17,438,534 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 13 Feb 2024 | CONVERSION | Metagenomi Therapeutics, Inc. | 1,180,592 | — | |
| 13 Feb 2024 | CONVERSION | Metagenomi Therapeutics, Inc. | 1,770,888 | — | |
| 13 Feb 2024 | CONVERSION | Metagenomi Therapeutics, Inc. | 509,855 | — | |
| 13 Feb 2024 | CONVERSION | Metagenomi Therapeutics, Inc. | 589,662 | — | |
| 13 Feb 2024 | CONVERSION | Metagenomi Therapeutics, Inc. | 3,093,580 | 0.00 USD | deriv |
| 13 Feb 2024 | CONVERSION | Metagenomi Therapeutics, Inc. | 890,671 | 0.00 USD | deriv |
| 13 Feb 2024 | CONVERSION | Metagenomi Therapeutics, Inc. | 1,030,086 | 0.00 USD | deriv |
| 13 Feb 2024 | CONVERSION | Metagenomi Therapeutics, Inc. | 2,062,387 | 0.00 USD | deriv |
| 21 Jun 2023 | CONVERSION | Azitra, Inc. | 1,307,401 | — | |
| 21 Jun 2023 | CONVERSION | Azitra, Inc. | 1,307,401 | 0.00 USD | deriv |
| 13 Oct 2021 | CONVERSION | Pyxis Oncology, Inc. | 2,742,338 | — | |
| 13 Oct 2021 | CONVERSION | Pyxis Oncology, Inc. | 11,362,462 | — | deriv |
| 13 Oct 2021 | CONVERSION | Pyxis Oncology, Inc. | 6,076,072 | — | deriv |
| 03 Dec 2020 | SALE | Elanco Animal Health Inc | 54,500,000 | 29.84 USD |